Gf Fund Management Co. Ltd. Merus N.V. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Merus N.V. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 1,753 shares of MRUS stock, worth $89,052. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,753
Previous 1,438
21.91%
Holding current value
$89,052
Previous $60.5 Million
22.02%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding MRUS
# of Institutions
195Shares Held
62.2MCall Options Held
355KPut Options Held
96.5K-
Wellington Management Group LLP Boston, MA4.72MShares$240 Million0.04% of portfolio
-
Commodore Capital LP New York, NY4.47MShares$227 Million18.43% of portfolio
-
Rtw Investments, LP New York, NY4.17MShares$212 Million2.88% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.37MShares$171 Million7.27% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.17MShares$161 Million3.38% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $2.33B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...